Positive/external control of rapid diagnostic tests: A step forward in malaria screening

QR Code

Positive/external control of rapid diagnostic tests: A step forward in malaria screening

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Rasika D Setia, Mitu Dogra, Anil Handoo, Prerna Sachdeva
Format:	article
Langue:	EN
Publié:	Wolters Kluwer Medknow Publications 2021
Sujets:	Diseases of the blood and blood-forming organs RC633-647.5
Accès en ligne:	https://doaj.org/article/83ffd870c5be4bcc9aeb07ff480852d2
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Looking forward by looking back: Inception of a new journal
par: Mary Cushman
Publié: (2020)

ACUTE MEGACARYOBLASTIC LEUKEMIA IN CHILDREN: DIAGNOSTICS AND MRD MONITORING
par: Aleksandra Palladina, et autres
Publié: (2021)

Reticulocyte Hemoglobin Equivalent: Diagnostic Performance in Assessment of Iron Deficiency in Patients with Hypothyroidism
par: Wardah Aslam, et autres
Publié: (2021)

DIAGNOSTIC APPLICATION AND CLINICAL SIGNIFICANCE OF FCM WELLS SCORING SYSTEM IN MYELODYSPLASTIC SYNDROMES
par: Reyhan Aliyeva, et autres
Publié: (2021)

External qualification of the Web‐Accessible Population Pharmacokinetic Service–Hemophilia (WAPPS‐Hemo) models for octocog alfa using real patient data
par: Pierre Chelle, et autres
Publié: (2021)

Trends in the treatment of cutaneous T-cell lymphoma &ndash; critical evaluation and perspectives on vorinostat
par: Zhang CL, et autres
Publié: (2012)

MicroRNA dysregulation in B-cell non-Hodgkin lymphoma
par: Lim EL, et autres
Publié: (2013)

Critical appraisal of belinostat in the management of T-cell lymphoma – patient considerations
par: Bodiford A, et autres
Publié: (2015)

The expanding role of bendamustine in chronic lymphocytic leukemia
par: Nair KS, et autres
Publié: (2015)

Bortezomib in autoimmune hemolytic anemia and beyond
par: Raffaella Pasquale, et autres
Publié: (2021)

Life-Threatening Retroperitoneal Hematoma in a Patient with COVID-19
par: Monarch Shah, et autres
Publié: (2021)

A method to determine if more than surrogate outcomes were improved: The EMR glitch experiment
par: Jennifer Gill, et autres
Publié: (2020)

All bleeding matters … but the details may not
par: Sarah H. O’Brien
Publié: (2020)

The Use of Etoposide, Ara-Cytarabine, and Melphalan (EAM) Conditioning Chemotherapy in Autologous Stem Cell Transplantation (ASCT) for a Patient with Relapsed Hodgkin’s Lymphoma
par: Eko A. Pangarsa, et autres
Publié: (2021)

PP Transcon 2020 Abstracts Compilation
Publié: (2021)

A rare case of mistaken identity - Historical blood group saved the situation
par: Anand Deshpande, et autres
Publié: (2021)

Oration - Dr Sanmukh Joshi
Publié: (2021)

OP Transcon 2020 Abstracts Compilation
Publié: (2021)

TRANSCON 2020 45th Annual Conference ISBTI 27th & 28th Feb 2021
Publié: (2021)

Clinical relevance of hepatitis B core total antibody in the detection of occult hepatitis B infection in patients with liver disease and blood donors
par: Vijeta Bajpai, et autres
Publié: (2021)

Long-term safety and efficacy of dasatinib in the treatment of chronic-phase chronic myeloid leukemia patients resistant or intolerant to imatinib
par: Shoumariyeh K, et autres
Publié: (2014)

MYC as therapeutic target in leukemia and lymphoma
par: Cortiguera MG, et autres
Publié: (2015)

Clinical potential of carfilzomib in the treatment of relapsed and refractory multiple myeloma
par: Gupta VA, et autres
Publié: (2013)

Optimal management of endemic Burkitt lymphoma: a holistic approach mindful of limited resources
par: Moormann AM, et autres
Publié: (2014)

Peripheral T cell lymphoma: clinical utility of romidepsin
par: Sawey K, et autres
Publié: (2012)

The evaluation and optimal use of rituximab in lymphoid malignancies
par: Smolewski P, et autres
Publié: (2012)

Impact of pharmacokinetics to reduce bleeding in a cohort of patients with severe hemophilia A in a personalized comprehensive management program
par: Samuel sarmiento Doncel, et autres
Publié: (2021)

Ultrastructural alterations of megakaryocytes in thrombocytopenia: A review of 43 cases
par: Brian Eyden, et autres
Publié: (2021)

Regulation of megakaryopoiesis by bone marrow macrophage polarization
par: Ming Hou
Publié: (2021)

The correlation between Flt3-ITD mutation in dendritic cells with TIM-3 expression in acute myeloid leukemia
par: Hooriyeh Shapoorian, et autres
Publié: (2021)

Immune targeted therapy for diffuse large B cell lymphoma
par: Yaxin Zheng, et autres
Publié: (2021)

Lymphoid-biased hematopoietic stem cells and myeloid-biased hematopoietic progenitor cells have radioprotection activity
par: Shanshan Zhang, et autres
Publié: (2021)

Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
par: Meletios A. Dimopoulos, et autres
Publié: (2021)

De Novo AL Amyloidosis in Renal Allograft and Anti-CD38 Monoclonal Antibody Treatment
par: Despina Fotiou, et autres
Publié: (2021)

Influence of Telomere Length on the Achievement of Deep Molecular Response With Imatinib in Chronic Myeloid Leukemia Patients
par: Natalia Estrada, et autres
Publié: (2021)

Summary of Joint European Hematology Association (EHA) and EuroBloodNet Recommendations on Diagnosis and Treatment of Methemoglobinemia
par: Achille Iolascon, et autres
Publié: (2021)

The European Medicines Agency Review of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
par: Julio Delgado, et autres
Publié: (2021)

New Perspectives of Interferon-alpha2 and Inflammation in Treating Philadelphia-negative Chronic Myeloproliferative Neoplasms
par: Hans C. Hasselbalch, et autres
Publié: (2021)

Obinutuzumab in Allogeneic Transplantation for CLL and Richter’s Transformation in the Age of Targeted Therapies
par: Natali Pflug, et autres
Publié: (2021)

Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia
par: Colin Vercueil, et autres
Publié: (2021)